Renoprotective effect of febuxostat on contrast-induced acute kidney injury in chronic kidney disease patients stage 3: randomized controlled trial.
Iman Ibrahim SarhanYasser A AbdellatifRania Elsayed SaadNahla Mohamed TeamaPublished in: BMC nephrology (2023)
We demonstrated that febuxostat has a Reno protective effect and it can help to reduce the incidence CI-AKI in CKD patients stage 3 performing PCI.
Keyphrases
- acute kidney injury
- end stage renal disease
- randomized controlled trial
- chronic kidney disease
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- coronary artery disease
- heart failure
- magnetic resonance
- study protocol
- systematic review
- risk factors
- magnetic resonance imaging
- acute myocardial infarction
- computed tomography
- cardiac surgery
- oxidative stress
- percutaneous coronary intervention
- atrial fibrillation
- diabetic rats
- coronary artery bypass grafting